NCT05990582Befejeződött
The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years
Neurodevelopmental Outcomes and Morbidities of Moderate and Late Preterm Children at the Age of 9 Years -The Alkmaar MLPTI Cohort Study
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. szept. 1.
Rövid összefoglaló (regiszter, angolul)
Objective of the study: To examine cognition, motor function, executive functions, speech and language development, behaviour, psychosocial functioning,academic achievement, physical morbidities and growth of MLPTI at the age of 9 years and correlate this with BSID-III-NL scores,growth parameters and body composition at the age of 2 years. Study design: This study will be a prospective open, non-therapeutic exploratory cohort study and can be seen as a continuation on the study with protocol identification number NL50800.094.14, performed in the NWZ Alkmaar between 2014 and 2016. This was a study on growth and neurodevelopment of MLPTI in the first 2 years of life. Study population: The study population is a group of 200 moderate and late preterm children who were born in the NWZ Alkmaar between 2014 and 2016. 100 of these children participated in the aforementioned study on growth and neurodevelopment at the age of 2 years. The oldest children in this group will reach the age of 9 years in 2023. Brothers/sisters/friends of these children aged between 8 and 10 will be asked as control group and also 9 year old children who are living in the area of Alkmaar (< 20 km) and who are invited by the GGD to receive vaccinations at the age of 9 years old or 9 year old children of employees of Noordwest Hospital and all born at full term. (n=70). Primary study parameters/outcome of the study: The main study parameters are the IQ-scores of the WISC-V, the motoric scores of the Movement-ABC, the executive functions of the EMMA Toolbox, the presence of morbidities, the growth pattern and the mean blood pressure at 9 years of age. Secondary study parameters/outcome of the study: Secondary outcome parameters are the he behavioural and psychosocial outcomes of the CBCL and the SDQ scores, speech-and language-developmental scores of the CELF-5-NL and CCC-2-NL, MCH Feeding Scale and Teacher Report Form (TRF) scores. Other outcome parameters are the relation between the 9-year outcomes and the BSID-III scores at the age of 2, and the differences between the MLPTI and the control group. Furthermore, we aim to determine the relation between growth and body composition in the first two years of life and the waist circumference, growth parameters and blood pressure at the age of 9 years.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 153 (tényleges)
- Első benyújtás
- 2023. júl. 25.
- Kezdés
- 2023. aug. 11.
- Elsődleges befejezés
- 2026. júl. 4.
- Fő szponzor
- Noordwest Ziekenhuisgroep
- NCT-szám
- NCT05990582
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Bevont résztvevők: 153
- 2023. aug. 11. és az elsődleges befejezés (2026. júl. 4.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
A regiszterben nem jelölt feltételek
- In order to be eligible to participate in this study, a subject must meet all the following criteria:
- The participant is born in or transferred to the NWZ Alkmaar between January 1st, 2014 and April 18th, 2016 (the time in which the participants of trial NL50800.094.14 were born).
- The participant born at a gestational age from 32 to 35+6 weeks.
- Both parents of the participant have given informed consent to participate in the 9 years trial
- In order to be eligible to participate in the control group of this study, a subject must meet all the following criteria:
- The participant is 9 years old when participating in this study and is a friend or classmate of the included MLPTI or has visited a GGD site for the 9 years vaccination and is willing to participate or is a (grand)child of an employee of Noordwest Hospital and is living in the area of Alkmaar (< 20 km).
- Both parents of the participant have given informed consent for the participation of the study.
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- The participant's parents are not able to fill out questionnaires or perform tests in Dutch.
- The participant has a severe developmental or genetic disorder and is thereby not able to perform the tests.
- The participant is not able to come to the outpatient clinic to do the tests.
- A potential subject who meets any of the following criteria will be excluded from participation in this study as part of the control group:
- The participant is born with a GA < 37 weeks.
- The participant has a severe developmental or genetic disorder and is thereby not able to perform the tests.
- The participant had complications after birth (e.g. admission at a Neonatal ward)
- The participant needs special education
Életkor a regiszterben: 9 év – 9 év · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Noordwest Ziekenhuisgroep | Alkmaar | Hollandia | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.